The prevalence of beta amyloid plaques is an important marker in the epidemiology of Alzheimer’s Disease. Understanding their distribution, determinants, and impact can provide insights into the etiology and progression of AD. Epidemiological studies often focus on the prevalence and incidence of beta amyloid plaques in various populations to identify risk factors and potential preventative measures.
